Tag: MiRus

MiRus receives FDA clearance for IO Expandable Lumbar Interbody

MiRus has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its IO Expandable Lumbar Interbody, a device which...

MiRus raises US$65 million for expansion of Rhenium-based devices

MiRus has raised US$65 million in a new funding round that will help the firm grow its spinal and extremity portfolios and development of...

MiRus announces a lifetime limited warranty on MoRe superalloy rod 

MiRus has announced the launch of MoRe Promise, a lifetime limited warranty on its Molybdenum-Rhenium (MoRe) superalloy rod technology. In a company press release,...

MiRus announces first clinical use of the 3DR printed lumbar interbody...

MiRus has announced that it received US Food and Drug Administration (FDA) 510(k) clearance for its 3DR (randomised) printed lumbar interbody fusion system which...
fda

GALILEO spine alignment monitoring system receives FDA clearance

MiRus has announced US Food and Drug Administration (FDA) 510(k) clearance of the GALILEO spine alignment monitoring system, a non-optical, wireless, real-time measurement system...